{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:10:02Z","timestamp":1750032602363,"version":"3.41.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec><jats:title>Objectives:<\/jats:title><jats:p>The role of radiotherapy (RT) in improving survival of patients with diffuse large B-cell lymphoma (DLBCL) of the Waldeyer ring (WR) remains controversial. Therefore, this retrospective cohort study aimed to determine the role of RT in the treatment of DLBCL of the WR as well as the effects of associated covariates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods:<\/jats:title><jats:p>Patients (n=35) with stage I to II DLBCL of the WR who underwent treatment at our center between 1994 and 2010 were retrospectively investigated. All patients had histologic diagnosis and staging workup completed. Overall survival (OS), event-free survival (EFS), and disease-free survival (DFS) were analyzed. Variables with a<jats:italic toggle=\"yes\">P<\/jats:italic>-value of &lt;0.1 were subjected to multivariate Cox proportional hazards model analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The median OS was 8.1 years. The 5-year OS, DFS, and EFS rates were 59.4%, 53.8%, and 70.7%, respectively; the corresponding 10-year rates were 34.9%, 29.5%, and 51.0%, respectively. The 5-year OS rate was significantly higher in the RT group than in the non-RT group (65.4% vs. 36.4%, respectively;<jats:italic toggle=\"yes\">P<\/jats:italic>=0.008). On multivariate analysis, RT was associated with improved OS (hazard ratio=0.15; 95% confidence interval [CI], 0.04-0.50;<jats:italic toggle=\"yes\">P<\/jats:italic>=0.002) and EFS (hazard ratio=0.29; 95% CI, 0.095-0.86;<jats:italic toggle=\"yes\">P<\/jats:italic>=0.026). An Eastern Cooperative Oncology Group performance status &gt;1 and age above 60 years were also found to negatively influence OS and EFS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>RT was associated with improved OS and EFS in stage I to II DLBCL of the WR. Future prospective studies are required to confirm these findings.<\/jats:p><\/jats:sec>","DOI":"10.1097\/coc.0000000000000375","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T12:27:48Z","timestamp":1488544068000},"page":"802-806","source":"Crossref","is-referenced-by-count":4,"title":["The Role of Radiotherapy in Early-stage Primary Diffuse Large B-Cell Lymphoma of the Waldeyer Ring"],"prefix":"10.1097","volume":"41","author":[{"given":"Shing Fung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting Ying","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank Chi Sing","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stewart Yuk","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230903","first-page":"1057","article-title":"Non-Hodgkin lymphomas of Waldeyer\u2019s ring","volume":"53","author":"Salplahta","year":"2012","journal-title":"Rom J Morphol Embryol"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anndiagpath.2005.09.020","article-title":"Extranodal lymphomas of the head and neck","volume":"9","author":"Vega","year":"2005","journal-title":"Ann Diagn Pathol"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1052-5149(03)00039-X","article-title":"Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation","volume":"13","author":"Weber","year":"2003","journal-title":"Neuroimaging Clin N Am"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00277-013-1856-4","article-title":"Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study)","volume":"93","author":"Mian","year":"2014","journal-title":"Ann Hematol"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/annonc\/mds150","article-title":"Diffuse large B-cell lymphoma of Waldeyer\u2019s ring has distinct clinicopathologic features: a GELA study","volume":"23","author":"De Leval","year":"2012","journal-title":"Ann Oncol"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2005.07.155","article-title":"Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin","volume":"23","author":"L\u00f3pez-Guillermo","year":"2005","journal-title":"J Clin Oncol"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijrobp.2009.07.1706","article-title":"Involved-lesion radiation therapy after chemotherapy in limited-stage head-and-neck diffuse large B cell lymphoma","volume":"78","author":"Yu","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijrobp.2004.04.034","article-title":"Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin\u2019s lymphoma of the head and neck","volume":"60","author":"Nishioka","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.clon.2003.10.010","article-title":"Localised extranodal lymphoma of the head and neck: the Sheffield Lymphoma Group experience (1971-2000)","volume":"16","author":"Hart","year":"2004","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.kjms.2012.02.014","article-title":"Head and neck extranodal lymphoma in a single institute: a 17-year retrospective analysis","volume":"28","author":"Chi","year":"2012","journal-title":"Kaohsiung J Med Sci"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0964-1955(95)00058-5","article-title":"Treatment of non-Hodgkin\u2019s lymphoma of Waldeyer\u2019s ring: radiotherapy versus chemotherapy versus combined therapy","volume":"32B","author":"Avil\u00e9s","year":"1996","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1200\/JCO.2007.13.6929","article-title":"Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014","volume":"26","author":"Persky","year":"2008","journal-title":"J Clin Oncol"},{"key":"R14-20230903","first-page":"724a","article-title":"CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin\u2019s lymphomas: update of the Southwest Oncology Group (SWOG) randomized trial","volume":"98","author":"Miller","year":"2001","journal-title":"Blood"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N Engl J Med"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"R18-20230903","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/COC.0b013e318187ddbb","article-title":"Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer\u2019s ring","volume":"32","author":"Chang","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"R20-20230903","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/hed.1077","article-title":"Localized non-Hodgkin\u2019s lymphoma of Waldeyer\u2019s ring: clinical features, management, and prognosis of 130 adult patients","volume":"23","author":"Ezzat","year":"2001","journal-title":"Head Neck"},{"key":"R21-20230903","first-page":"2837","article-title":"Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN)","volume":"17","author":"Pasini","year":"1997","journal-title":"Anticancer Res"},{"key":"R22-20230903","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/02841869309092451","article-title":"Stage IA non-Hodgkin\u2019s lymphoma of the Waldeyer\u2019s ring. Limited chemotherapy and radiation therapy versus radiation therapy alone","volume":"32","author":"Uematsu","year":"1993","journal-title":"Acta Oncol"},{"key":"R23-20230903","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/10428194.2012.710907","article-title":"Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer\u2019s ring in remission after anthracycline-containing chemotherapy","volume":"54","author":"Mian","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"R24-20230903","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.2002.20.1.197","article-title":"Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency","volume":"20","author":"Shenkier","year":"2002","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000421-201808000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T23:50:31Z","timestamp":1750031431000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201808000-00013"}},"subtitle":["A Retrospective Cohort Study"],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000375","relation":{},"ISSN":["0277-3732"],"issn-type":[{"type":"print","value":"0277-3732"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}